GlassScriptPhysician profile
Oscar Martinez Lopez
NPI 1104104264
$5,809.17
in general payments reported to CMS, 2019-2025
14 companies · $5,092 in 2025
The $5,092 reported for 2025 was more than what 90% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $29.99 · 2021: $59.99 · 2022: $215 · 2023: $13.10 · 2024: $43.97 · 2025: $5,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $648.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $4,500.00 | 2025 | |
| Gilead Sciences, INC. | $240.01 | 2024-2025 | Biktarvy |
| Abbvie INC. | $214.57 | 2022 | |
| Astellas Pharma US INC | $174.95 | 2019-2021 | |
| Insmed, INC. | $125.03 | 2023-2025 | Arikayce, Brinsupri |
| Paratek Pharmaceuticals, INC. | $125.00 | 2025 | Nuzyra |
| Viiv Healthcare Company | $122.01 | 2019 | |
| Merck Sharp & Dohme LLC | $95.79 | 2025 | Zerbaxa |
| E.R. Squibb & Sons, L.L.C. | $75.40 | 2019 | |
| Hologic Sales and Service, LLC | $40.08 | 2025 | Aptima |
| Janssen Products, LP | $29.99 | 2020 | |
| Janssen Pharmaceuticals, INC | $26.15 | 2019 | |
| Shionogi INC | $23.06 | 2025 | Fetroja |
| Janssen Biotech, INC. | $17.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Martinez Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.